Andrés Castaño-García

6PUBLICATIONS
41CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Translation and interpretation studiesPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 29, 2025
Challenges of using bevacizumab for hepatocellular carcinoma: incidence of adverse effects and mitigation strategies.

Marta García-Calonge, Andrés Castaño-García, Ana María Piedra Cerezal

|Jul 30, 2025
The role of immigration in chronic hepatitis B and C in Asturias - Origin and characteristics of the patients. An observational, cross-sectional study.

Ángela Suárez-Noya, Carmen Álvarez-Navascués, Mercedes Rodríguez

|Feb 19, 2025
Demographic and survival characteristics of untreated hepatocellular carcinoma patients: insights into the natural history and prognostic determinants.

Helena González-Sánchez, Andrés Castaño-García, Miriam Celada-Sendino

|Oct 13, 2021
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.

María José García, Montserrat Rivero, José Miranda-Bautista

Pageof 1